Skip to content

Home
About Us
Device Development
Investing
News
Contact Us

Contact Us

Genesis Innovation Group
13827 Port Sheldon St.
Holland, MI 49424

(616) 294-1026

Stay Connected With Us

Sign up to receive email updates on our latest news.

* indicates required

Email Address *

First Name *

Last Name *

Search for:

Latest News

Embody Receives $2.5 Million Phase II Research Award
Genesis Innovation Group’s cultivate(MD)™ Capital Fund II, LP Announces Participation in Virtual Incision’s $20 Million Financing to Advance First-of-its-Kind Mini-Robot for General Surgery Abdominal Procedures
Virtual Incision Announces $20 Million Financing
Medical Startup Receives FDA Clearance
2020 ASAP Meeting

Genesis Services

Medical Device Development
Engineering
Regulatory
Operations
Finance
Commercialization

Investing

For Investors
For Companies Seeking Investment
Portfolio

News & Updates

Embody Receives $2.5 Million Phase II Research Award
Genesis Innovation Group’s cultivate(MD)™ Capital Fund II, LP Announces Participation in Virtual Incision’s $20 Million Financing to Advance First-of-its-Kind Mini-Robot for General Surgery Abdominal Procedures
Virtual Incision Announces $20 Million Financing

Contact Us

Genesis Innovation Group
13827 Port Sheldon St.
Holland, MI 49424

(616) 294-1026

Copyright © 2020 Genesis Innovation Group

This website may contain forward-looking statements within the meaning of the relevant sections of the Securities Act. The words “believes”, “anticipates”, “expects”, “plans”, “intends” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements and statements of expectations, plans and intent are subject to a number of risks and uncertainties. Genesis Innovation Group, LLC’s actual future results may differ materially or adversely from those described in the forward-looking statements as a result of, among other things, uncertainties and other matters described in this website, generally. Genesis Innovation Group, LLC undertakes no obligation to release the results of any revisions to these forward-looking statements that may be made to reflect any future events or circumstances. Genesis Innovation Group, LLC cautions the reader, however, that the identified uncertainties and other cautionary language contained herein may not be exhaustive. Nothing in this website shall be construed to be an offer to sell or a solicitation of an offer to purchase any particular securities. Any such offer or solicitation will be made only pursuant to definitive legal agreements prepared specifically for such purpose.